Sensitivity analysis of different HER2 clone numbers for detecting HER2 low and ultra-low expression in invasive breast cancer

被引：0
|
作者：
Liu, Y. [1 ]
Shang, J. [1 ]
He, J. [1 ]
Ding, Y. [1 ]
Li, J. [1 ]
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-02-05
引用
收藏
页码：S197 / S198
页数：2
相关论文
共 50 条
  • [21] Evaluating Low HER2 Status in Invasive Breast Carcinoma via HER2 Immunohistochemistry, with HER2 FISH Correlation: A Cohort of 112 Patients
    Ardor, Gokce Deniz
    Komforti, Miglena K.
    Hanna, Helena
    Ibanoglu, Onur
    Lochala, Abigail
    Nassar, Aziza
    BREAST JOURNAL, 2023, 2023
  • [22] Her2 low status and response to neoadjuvant chemotherapy in Her2 negative early breast cancer
    Mattos, Bruna RaphaeliSilva
    Cesca, Marcelle Goldner
    Leite, Luciana de Moura
    Tavares, Monique Celeste
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla AlbinaZanco
    Silva, Erick Figueiredo
    Rocha, Francisca Giselle
    Loose, Simone Klug
    Campos, Fernando AugustoBatista
    Sanches, Solange Moraes
    de Lima, Vladmir ClaudioCordeiro
    Ponde, Noam Falbel
    CANCER RESEARCH, 2021, 81 (04)
  • [23] The comparison of HER2 low and HER2 0 in ductal carcinoma in situ (DCIS) for breast cancer
    Kureyama, Nari
    Kusudo, Maho
    Nakakami, Akira
    Komaki, Rie
    Endo, Yuka
    Nozawa, Kazuki
    Kataoka, Ayumi
    Kotani, Haruru
    Yoshimura, Akiyo
    Hattori, Masaya
    Sawaki, Masataka
    Iwata, Hiroji
    CANCER RESEARCH, 2024, 84 (09)
  • [24] Survival analysis of HER2 receptor negative and HER2 receptor low breast cancer patients at a Philippine hospital
    Arenos, C. C.
    San Juan, M.
    Lim, S.
    Lominoque, A.
    Reveldez, I.
    Sison-DImaano, A.
    Pangandaman, N.
    Tatoy, V.
    Uy, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S1390 - S1390
  • [25] Think "HER2" different: integrative diagnostic approaches for HER2-low breast cancer
    Marchio, Caterina
    Criscitiello, Carmen
    Scatena, Cristian
    Santinelli, Alfredo
    Graziano, Paolo
    Malapelle, Umberto
    Cursano, Giulia
    Venetis, Konstantinos
    Fanelli, Giuseppe Nicolo
    Pepe, Francesco
    Berrino, Enrico
    De Angelis, Carmine
    Perrone, Giuseppe
    Curigliano, Giuseppe
    Fusco, Nicola
    PATHOLOGICA, 2023, 115 (06) : 292 - 301
  • [26] Computational pathology based HER2 expression quantification in HER2-low breast cancer
    Spitzmueller, Andreas
    Kapil, Ansh
    Shumilov, Anatoliy
    Chan, Jessica
    Konstantinidou, Lemonia
    Hassan, Zonera
    Gustavson, Mark
    Carroll, Danielle
    Della Varghese
    James, Gareth D.
    Moh, Akira
    Livingston, Andrew
    de Giorgio-Miller, Victoria
    CANCER RESEARCH, 2023, 83 (05)
  • [27] Ultra-low fouling methylimidazolium modified surfaces for the detection of HER2 in breast cancer cell lysates
    Aube, Alexandra
    Campbell, Shirley
    Schmitzer, Andreea R.
    Claing, Audrey
    Masson, Jean-Francois
    ANALYST, 2017, 142 (13) : 2343 - 2353
  • [28] HER2-Low Breast Cancer Can Be Visualized by HER2 PET
    Altena, Renske
    af Buren, Siri
    Tran, Thuy
    Axelsson, Rimma
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1842 - 1842
  • [29] A Comparative Analysis of the Value of Her2 Immunohistochemistry Scoring in Primary and Metastatic Breast Cancer, in the Era of Her2 "LOW" Breast Cancers
    Bhardwaj, Swati
    Kandel, Avi
    Collins, Victoria
    Zeizafoun, Nebras
    Zeng, Jennifer
    Jaffer, Shabnam
    LABORATORY INVESTIGATION, 2023, 103 (03) : S103 - S103
  • [30] Improving HER2 testing reproducibility in HER2-low breast cancer
    Sajjadi, Elham
    Venetis, Konstantinos
    Ivanova, Mariia
    Fusco, Nicola
    CANCER DRUG RESISTANCE, 2022, 5 (04) : 882 - 888
12345